Cargando…

Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities

Respiratory viral infections are the leading cause of death worldwide. The current pandemic of coronavirus infection (COVID-19) challenged human beings for the treatment and prevention of this respiratory viral infection since its outbreak in 2019. Despite advancements in the medical field, scientis...

Descripción completa

Detalles Bibliográficos
Autor principal:	Nainwal, Nidhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554202/ https://www.ncbi.nlm.nih.gov/pubmed/36240985 http://dx.doi.org/10.1016/j.pupt.2022.102170

Ejemplares similares

Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections
por: Loo, Ching-Yee, et al.
Publicado: (2023)

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
por: Simões, Eric A. F., et al.
Publicado: (2015)

Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities
por: Nichols, Dave P., et al.
Publicado: (2019)

Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead()
por: Velkov, Tony, et al.
Publicado: (2015)

Editorial: Immunity to Cytomegalovirus Infections: Challenges and Therapeutic Opportunities
por: Alonso-Arias, Rebeca, et al.
Publicado: (2022)

Challenges and Opportunities in Pharmacogenomics and Therapeutics
por: Kane, Michael D., et al.
Publicado: (2007)

Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities
por: Atanasio, Amanda, et al.
Publicado: (2022)

It's not all about inhaled treatment: challenges with oral therapy in paediatric respiratory medicine
por: Sareen, Anneka, et al.
Publicado: (2021)

FDA Coronavirus Treatment Acceleration Program: approved drugs and those in clinical trials
por: Nainwal, Lalit Mohan, et al.
Publicado: (2022)

Respiratory Medicine in China: Progress, Challenges, and Opportunities
por: Wang, Chen, et al.
Publicado: (2013)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

Lipogenesis inhibitors: therapeutic opportunities and challenges
por: Batchuluun, Battsetseg, et al.
Publicado: (2022)

Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges
por: Ademe, Muluneh
Publicado: (2020)

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
por: Sécher, Thomas, et al.
Publicado: (2019)

Nasally inhaled therapeutics and vaccination for COVID‐19: Developments and challenges
por: Xi, Jinxiang, et al.
Publicado: (2021)

Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities
por: Mahmoud, Ahmed M, et al.
Publicado: (2023)

Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy
por: Silva, Valdenizia R., et al.
Publicado: (2020)

The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities
por: Bayati, Fatemeh, et al.
Publicado: (2021)

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
por: Hammond, Suzan M, et al.
Publicado: (2021)

Bilirubin as a Therapeutic Molecule: Challenges and Opportunities
por: Adin, Christopher A.
Publicado: (2021)

Eicosanoids and Respiratory Viral Infection: Coordinators of Inflammation and Potential Therapeutic Targets
por: McCarthy, Mary K., et al.
Publicado: (2012)

Impact of inhaled pollutants on response to viral infection in controlled exposures
por: Rebuli, Meghan E., et al.
Publicado: (2021)

Viral Respiratory Infections
por: van Doorn, H Rogier, et al.
Publicado: (2013)

Respiratory Viral Infections
por: Proença-Módena, José Luiz, et al.
Publicado: (2011)

Viral Respiratory Infections
por: van Doorn, H. Rogier, et al.
Publicado: (2020)

Respiratory viral infections
por: Falsey, Ann Regina
Publicado: (2019)

SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
por: Coke, Christopher J., et al.
Publicado: (2021)

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
por: Muralidharan, Priya, et al.
Publicado: (2014)

Hemophagocytic lymphohistiocytosis associated with viral infections: Diagnostic challenge and therapeutic dilemma()
por: Mostaza-Fernández, J.L., et al.
Publicado: (2014)

Respiratory Immune Responses during Infection and Pollution Inhalation
por: McCarthy, Cormac, et al.
Publicado: (2023)

Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections
por: Asha, Kumari, et al.
Publicado: (2018)

Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges
por: Lei, Xiaotian, et al.
Publicado: (2022)

Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
por: Li, De‐feng, et al.
Publicado: (2023)

Potential benefits of ibuprofen in the treatment of viral respiratory infections
por: Winther, Birgit, et al.
Publicado: (2003)

Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections
por: Sies, Helmut, et al.
Publicado: (2020)

PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
por: Murray, Alison, et al.
Publicado: (2020)

Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
por: Zhuo, Shenghua, et al.
Publicado: (2022)

Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities
por: Lange, Jenny, et al.
Publicado: (2022)

Therapeutic Potential of Regulatory T Cells in Preeclampsia—Opportunities and Challenges
por: Robertson, Sarah A., et al.
Publicado: (2019)

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
por: Pathania, Anup S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0akh5sg1op3krbcdm14p5v795h